IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases

Research output: Contribution to journalReview articlepeer-review


Insulin-like growth factor 2 (IGF2) emerged as a critical mechanism of synaptic plasticity and learning and memory. Deficits in IGF2 in the brain, serum, or cerebrospinal fluid (CSF) are associated with brain diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS). Increasing IGF2 levels enhances memory in healthy animals and reverses numerous symptoms in laboratory models of aging, neurodevelopmental disorders, and neurodegenerative diseases. These effects occur via the IGF2 receptor (IGF2R) – a receptor that is highly expressed in neurons and regulates protein trafficking, synthesis, and degradation. Here, I summarize the current knowledge regarding IGF2 expression and functions in the brain, particularly in memory, and propose a novel conceptual model for IGF2/IGF2R mechanisms of action in brain health and diseases.

Original languageEnglish (US)
Pages (from-to)488-502
Number of pages15
JournalTrends in Neurosciences
Issue number6
StatePublished - Jun 2023


  • IGF2 receptor
  • cation-independent mannose 6 phosphate receptor
  • memory
  • neurodegenerative disease
  • neurodevelopmental disorder
  • protein metabolism

ASJC Scopus subject areas

  • General Neuroscience


Dive into the research topics of 'IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases'. Together they form a unique fingerprint.

Cite this